Last reviewed · How we verify
ATG-F
ATG-F is a Small molecule drug developed by Astellas Pharma Inc. It is currently FDA-approved.
At a glance
| Generic name | ATG-F |
|---|---|
| Sponsor | Astellas Pharma Inc |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders (PHASE2)
- Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases (PHASE2)
- Personalized NK Cell Therapy in CBT (PHASE2)
- Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults (PHASE2)
- Efficacy and Safety of Two Anti-T-lymphocyte Immune Globulin (ATG-F) Induction Regimens in Anew Kidney Transplant Patients (PHASE4)
- Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer (PHASE1)
- Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies (EARLY_PHASE1)
- Observational Study to Evaluate the Safety and Efficacy of ATG-F on Kidney Transplant Recipients
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ATG-F CI brief — competitive landscape report
- ATG-F updates RSS · CI watch RSS
- Astellas Pharma Inc portfolio CI
Frequently asked questions about ATG-F
What is ATG-F?
ATG-F is a Small molecule drug developed by Astellas Pharma Inc.
Who makes ATG-F?
ATG-F is developed and marketed by Astellas Pharma Inc (see full Astellas Pharma Inc pipeline at /company/astellas).
What development phase is ATG-F in?
ATG-F is FDA-approved (marketed).
Related
- Manufacturer: Astellas Pharma Inc — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing